Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation

Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation

(2020) Ruth Van Daele et al.   Expert Opinion on Drug Metabolism & Toxicology

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

(2018) Marlou L. P. S. van Iersel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients

(2018) Fekade B. Sime et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children

(2018) Sophida Boonsathorn et al.   CLINICAL PHARMACOKINETICS

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Invasive pulmonary aspergillosis complicating severe influenza

(2018) Lore Vanderbeke et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

(2017) Oliver A Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

(2016) Oliver A. Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis

(2014) Michael J. Dolton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects

(2014) Wendy M. Kersemaekers et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside

(2014) Seyedmojtaba Seyedmousavi et al.   DRUG RESISTANCE UPDATES

Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit

(2012) Dominic Störzinger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Introduction to Drug Pharmacokinetics in the Critically III Patient

(2012) Brian S. Smith et al.   CHEST

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study

(2012) Joost Wauters et al.   INTENSIVE CARE MEDICINE

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

(2012) Kiran Shekar et al.   JOURNAL OF CRITICAL CARE

Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation

(2009) V. Kohl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome

(2009) M.A. AbuTarif et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

(2009) I. Spriet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation

(2008) Stéphanie Ruiz et al.   INTENSIVE CARE MEDICINE